Xactagen has developed technology that makes reporter cells (also referred to as reporter gene assays) a powerful tool for understanding gene expression and genetic activity in biological research and drug discovery. View company details

The International Food Policy Research Institute (IFPRI) seeks sustainable solutions for ending hunger and poverty. Founded in 1975, IFPRI is a CGIAR Research Center. IFPRI's vision is "A World Free of Hunger and Malnutrition." IFPRI is an equal opportunity employer that provides researchers and professionals a collaborative environment to reduce hunger, poverty, and malnutrition worldwide through evidence-based research. We have been repeatedly ... View company details

XBiotech Inc., a pre-market biopharmaceutical company, engages in discovering and developing True Human monoclonal antibodies for treating various diseases. The company's lead product is bermekimab, a therapeutic antibody that neutralizes interleukin-1 alpha, which has completed Phase III clinical trial in Europe for the treatment of symptomatic and advanced colorectal cancer. It has also investigating its lead product candidate in various clinic... View company details

We enable our customers to set-up highly robust bulk drug substance freeze/transportation/storage processes with single-use bags. Through that, our customers are able to increase patient safety and reduce the risk of bio-contamination and product loss. View company details

X-Chem is a biotechnology company that utilizes DNA-encoded drug discovery engine for the generation of novel-based small molecule therapeutics. View company details

Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and other protein therapeutics to treat severe and life threatening diseases with unmet medical needs. It develops its antibody product candidates to treat autoimmune and allergic diseases, cancer, and other conditions. The company's product candidates include XmAb5871, an immune inhibitor, which has been completed ... View company details

Xenetic Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progesterone resistant endometrial cancer. Its proprietary drug development platform, PolyXen, enables next-generation biologi... View company details

Xhale develops sensors that analyze exhaled breath and is focused on novel patient-centric monitoring solutions. View company details